Clinical Trials Directory

Trials / Completed

CompletedNCT07023705

MLPR As A Diagnostic Marker For Acute Pulmonary Embolism

Monocyte To Large Platelet Ratio As A Diagnostic Marker For Acute Pulmonary Embolism

Status
Completed
Phase
Study type
Observational
Enrollment
37 (actual)
Sponsor
Ain Shams University · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

A retrospective study to assess the utility of hematological marker (monocyte to large platelet ratio) to diagnose patients with pulmonary embolism

Detailed description

The investigators conducted a retrospective review of emergency department records of patients who presented with signs and symptoms suggestive of pulmonary embolism (PE) and underwent CT pulmonary angiography (CTPA) for diagnosis. Hematological laboratory findings obtained prior to any treatment were collected and compared between two groups based on CTPA results: those with confirmed PE (CT positive) and those without PE (CT negative).

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTMonocyte to Large Platelet Ratio (MLPR)Admission laboratory values were used to calculate the Monocyte-to-Large Platelet Ratio (MLPR) by dividing the absolute monocyte count by the large platelet count. These values were obtained from blood samples collected before any treatment was administered.

Timeline

Start date
2024-01-01
Primary completion
2024-12-31
Completion
2025-05-31
First posted
2025-06-17
Last updated
2025-06-19

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT07023705. Inclusion in this directory is not an endorsement.